The estimated Net Worth of Bret Christensen is at least $9.63 Milion dollars as of 18 November 2022. Mr. Christensen owns over 3,000 units of Insulet stock worth over $3,769,159 and over the last 7 years he sold PODD stock worth over $3,541,836. In addition, he makes $2,318,720 as Executive Vice President and Chief Commercial Officer at Insulet.
Bret has made over 5 trades of the Insulet stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 3,000 units of PODD stock worth $885,450 on 18 November 2022.
The largest trade he's ever made was selling 5,000 units of Insulet stock on 12 August 2020 worth over $1,007,700. On average, Bret trades about 583 units every 29 days since 2017. As of 18 November 2022 he still owns at least 16,551 units of Insulet stock.
You can see the complete history of Mr. Christensen stock trades at the bottom of the page.
Bret Christensen serves as Executive Vice President and Chief Commercial Officer of the Company. Mr. Christensen has served as our Executive Vice President and Chief Commercial Officer since February 2019. From May 2017 to February 2019, Mr. Christensen served as our Senior Vice President and Chief Commercial Officer. From August 2013 to May 2017, Mr. Christensen served as General Manager of Preventive Care of Myriad Genetics, Inc. From 2009 to July 2013, Mr. Christensen served as Vice President, Sales and Marketing of Hologic, Inc. Prior to 2009, Mr. Christensen held several leadership roles at Hologic, including District Sales Manager and Regional Business Director. Mr. Christensen earned a Bachelor of Science in Business Management from Utah Valley University and received a Master of Business Administration from the University of Utah.
As the Executive Vice President and Chief Commercial Officer of Insulet, the total compensation of Bret Christensen at Insulet is $2,318,720. There are 3 executives at Insulet getting paid more, with Shacey Petrovic having the highest compensation of $5,883,980.
Bret Christensen is 49, he's been the Executive Vice President and Chief Commercial Officer of Insulet since 2019. There are 18 older and 4 younger executives at Insulet. The oldest executive at Insulet Corporation is John Fallon, 72, who is the Independent Director.
Bret's mailing address filed with the SEC is 12340 EL CAMINO REAL, , SAN DIEGO, CA, 92130.
Over the last 18 years, insiders at Insulet have traded over $64,849,299 worth of Insulet stock and bought 175,262 units worth $7,280,516 . The most active insiders traders include Jonathan Silverstein, Elizabeth H Weatherman oraz Samuel D Colella. On average, Insulet executives and independent directors trade stock every 19 days with the average trade being worth of $2,473,148. The most recent stock trade was executed by Timothy J Scannell on 10 September 2024, trading 5,000 units of PODD stock currently worth $1,129,200.
insulet corporation is an innovative medical device company based in billerica, massachusetts. it was founded in 2000 with the mission of improving the lives of people with diabetes. specifically, through its revolutionary omnipod insulin management system, insulet seeks to expand the use of insulin pump therapy. studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (mdi); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. despite these benefits, most people still choose mdi therapy largely due to the complexity, cost and inconvenience of conventional pump technology. the omnipod is a discreet and easy-to-use system that eliminates many of the issues associated with conventional pumps. improvements include omnipod's lack of tubing; automated, virtually pain-free insertion; and two straightforward parts that communicate wirelessly. by breaking down
Insulet executives and other stock owners filed with the SEC include: